Trial Profile
A pharmacokinetic study of testosterone transdermal [LibiGel] in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2011
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Estradiol; Estradiol congeners
- Indications Female sexual dysfunction
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- 16 Nov 2011 Results presented in a BioSante Pharmaceuticals media release.
- 13 Sep 2011 New trial record